Literature DB >> 27868470

Perinatal outcomes and cost-effectivity of the assisted reproduction pregnancies with advanced age: A retrospective analysis.

Nafiye Yilmaz1, Mustafa Kara2, Bugra Coskun1, Metin Kaba3, Selçuk Erkilinc1, Okan Yenicesu1, Salim Erkaya1.   

Abstract

We demonstrated the IVF-ICSI results, perinatal outcomes and cost-effectivity of the patients with advanced age at a tertiary centre. A total of 456 patients categorised into two groups according to age: group 1 (n = 158) (≥39years) and group 2 (n = 298) (<39years) were analysed retrospectively. In addition, subgroup analysis was performed according to the 40 years cut-off. Clinical pregnancy rate was significantly different between the groups (p< .001). Preterm delivery (< 37 gestational week) and low birth weight (< 2500 g) were significantly higher in advanced aged women than youngsters (p< .001). Mean expense per cycle for hormonal stimulation of IVF-ICSI was 1058.9 and 723.5 USD in groups 1 and 2, respectively (p< .001). Mean expense per pregnancy was 9294.7 and 1874.8 USD in groups 1 and 2, respectively (p< .001). Our study showed that perinatal outcomes and cost-effectivity might be adversely affected with increasing age.

Entities:  

Keywords:  Advanced age; IVF-ICSI; cost-effectivity; infertility; perinatal outcomes

Mesh:

Year:  2016        PMID: 27868470     DOI: 10.1080/01443615.2016.1251887

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

Review 1.  The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions.

Authors:  Laura Secomandi; Michela Borghesan; Michael Velarde; Marco Demaria
Journal:  Hum Reprod Update       Date:  2022-02-28       Impact factor: 15.610

2.  Cell-Free Fat Extract Improves Ovarian Function and Fertility in Mice With Advanced Age.

Authors:  Mengyu Liu; Wenzhu Li; Xiaowei Zhou; Mingjuan Zhou; Wenjie Zhang; Qiang Liu; Aijun Zhang; Bufang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-16       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.